Ahmad I - Search Results

1

Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities.

Gangwal A, Ansari A, Ahmad I, Azad AK, Kumarasamy V, Subramaniyan V, Wong LS. Gangwal A, et al. Among authors: ahmad i. Front Pharmacol. 2024 Feb 7;15:1331062. doi: 10.3389/fphar.2024.1331062. eCollection 2024. Front Pharmacol. 2024. PMID: 38384298 Free PMC article. Review.

2

Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC).

Pawara R, Ahmad I, Nayak D, Wagh S, Wadkar A, Ansari A, Belamkar S, Surana S, Nath Kundu C, Patil C, Patel H. Pawara R, et al. Among authors: ahmad i. Bioorg Chem. 2021 Oct;115:105234. doi: 10.1016/j.bioorg.2021.105234. Epub 2021 Aug 8. Bioorg Chem. 2021. PMID: 34399322

3

Rhamnetin, a nutraceutical flavonoid arrests cell cycle progression of human ovarian cancer (SKOV3) cells by inhibiting the histone deacetylase 2 protein.

Bharadwaj KK, Rabha B, Ahmad I, Mathew SP, Bhattacharjee CK, Jaganathan BG, Poddar S, Patel H, Subramaniyan V, Chinni SV, Ramachawolran G, Saleem R, Khalifa Ali EH, Abdel-Daim MM, Baishya D, Ghosh A. Bharadwaj KK, et al. Among authors: ahmad i. J Biomol Struct Dyn. 2023 Nov 28:1-16. doi: 10.1080/07391102.2023.2275187. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 38014451

4

Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors.

Ahmad I, Jadhav H, Shinde Y, Jagtap V, Girase R, Patel H. Ahmad I, et al. In Silico Pharmacol. 2021 Mar 23;9(1):23. doi: 10.1007/s40203-021-00086-x. eCollection 2021. In Silico Pharmacol. 2021. PMID: 33854869 Free PMC article.

5

Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation.

Pawara R, Ahmad I, Surana S, Patel H. Pawara R, et al. Among authors: ahmad i. In Silico Pharmacol. 2021 Oct 6;9(1):54. doi: 10.1007/s40203-021-00113-x. eCollection 2021. In Silico Pharmacol. 2021. PMID: 34631361 Free PMC article.

6

A reverse docking approach to explore the anticancer potency of natural compounds by interfering metastasis and angiogenesis.

Prome AA, Robin TB, Ahmed N, Rani NA, Ahmad I, Patel H, Bappy MNI, Zinnah KMA. Prome AA, et al. Among authors: ahmad i. J Biomol Struct Dyn. 2023 Aug 1:1-16. doi: 10.1080/07391102.2023.2240895. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37526218

7

Potent Bioactive Compounds From Seaweed Waste to Combat Cancer Through Bioinformatics Investigation.

Bharadwaj KK, Ahmad I, Pati S, Ghosh A, Sarkar T, Rabha B, Patel H, Baishya D, Edinur HA, Abdul Kari Z, Ahmad Mohd Zain MR, Wan Rosli WI. Bharadwaj KK, et al. Among authors: ahmad i, ahmad mohd zain mr. Front Nutr. 2022 Apr 22;9:889276. doi: 10.3389/fnut.2022.889276. eCollection 2022. Front Nutr. 2022. PMID: 35529456 Free PMC article.

8

Broadening the scope of WEE1 inhibitors: identifying novel drug candidates via computational approaches and drug repurposing.

Chandrasekaran J, Sivakumaresan Y, Shankar K, Dickson M, Laya Saravana Kumar S, Ramanathan L, Ahmad I, Patel H. Chandrasekaran J, et al. Among authors: ahmad i. J Biomol Struct Dyn. 2023 Aug 26:1-11. doi: 10.1080/07391102.2023.2251070. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37632319

9

BREED based de novo hybridization approach: generating novel T790M/C797S-EGFR tyrosine kinase inhibitors to overcome the problem of mutation and resistance in non small cell lung cancer (NSCLC).

Patel HM, Shaikh M, Ahmad I, Lokwani D, Surana SJ. Patel HM, et al. Among authors: ahmad i. J Biomol Struct Dyn. 2021 May;39(8):2838-2856. doi: 10.1080/07391102.2020.1754918. Epub 2020 Apr 23. J Biomol Struct Dyn. 2021. PMID: 32276580

10

In-vitro anticancer evaluation of newly designed and characterized tri/tetra-substituted imidazole congeners- maternal embryonic leucine zipper kinase inhibitors: Molecular docking and MD simulation approaches.

Mahapatra M, Mohapatra P, Pakeeraiah K, Bandaru RK, Ahmad I, Mal S, Dandela R, Sahoo SK, Patel H, Paidesetty SK. Mahapatra M, et al. Among authors: ahmad i. Int J Biol Macromol. 2023 Sep 30;249:126084. doi: 10.1016/j.ijbiomac.2023.126084. Epub 2023 Aug 1. Int J Biol Macromol. 2023. PMID: 37532192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,180 results

Search Page